{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T23:45:42Z","timestamp":1767570342392,"version":"3.48.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,4]]},"DOI":"10.7759\/cureus.100765","type":"journal-article","created":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T23:34:56Z","timestamp":1767569696000},"source":"Crossref","is-referenced-by-count":0,"title":["Necrotizing Soft Tissue Infection at a Self-Administered Subcutaneous Etanercept Injection Site in an Immunosuppressed Patient With Rheumatoid Arthritis: A Case Report"],"prefix":"10.7759","author":[{"given":"Seigo","family":"Tai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Takemoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihiro","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takaaki","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitaka","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1600673","article-title":"Necrotizing soft-tissue infections","volume":"377","author":"Stevens DL","year":"2017","unstructured":"Stevens DL, Bryant AE. Necrotizing soft-tissue infections. N Engl J Med. 2017, 377:2253-65. 10.1056\/NEJMra1600673","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu296","article-title":"Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America","volume":"59","author":"Stevens DL","year":"2014","unstructured":"Stevens DL, Bisno AL, Chambers HF, et al.. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014, 59:147-59. 10.1093\/cid\/ciu296","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1067\/j.cpsurg.2014.06.001","article-title":"Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes","volume":"51","author":"Hakkarainen TW","year":"2014","unstructured":"Hakkarainen TW, Kopari NM, Pham TN, Evans HL. Necrotizing soft tissue infections: review and current concepts in treatment, systems of care, and outcomes. Curr Probl Surg. 2014, 51:344-62. 10.1067\/j.cpsurg.2014.06.001","journal-title":"Curr Probl Surg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/sur.2019.219","article-title":"Necrotizing soft tissue infections: a focused review of pathophysiology, diagnosis, operative management, antimicrobial therapy, and pediatrics","volume":"21","author":"Tessier JM","year":"2020","unstructured":"Tessier JM, Sanders J, Sartelli M, et al.. Necrotizing soft tissue infections: a focused review of pathophysiology, diagnosis, operative management, antimicrobial therapy, and pediatrics. Surg Infect (Larchmt). 2020, 21:81-93. 10.1089\/sur.2019.219","journal-title":"Surg Infect (Larchmt)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccm.0000129486.35458.7d","article-title":"The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections","volume":"32","author":"Wong CH","year":"2004","unstructured":"Wong CH, Khin LW, Heng KS, Tan KC, Low CO. The LRINEC (Laboratory Risk Indicator for Necrotizing Fasciitis) score: a tool for distinguishing necrotizing fasciitis from other soft tissue infections. Crit Care Med. 2004, 32:1535-41. 10.1097\/01.ccm.0000129486.35458.7d","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002774","article-title":"Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and meta-analysis","volume":"269","author":"Fernando SM","year":"2019","unstructured":"Fernando SM, Tran A, Cheng W, et al.. Necrotizing soft tissue infection: diagnostic accuracy of physical examination, imaging, and LRINEC score: a systematic review and meta-analysis. Ann Surg. 2019, 269:58-65. 10.1097\/SLA.0000000000002774","journal-title":"Ann Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-008-1373-4","article-title":"Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management","volume":"35","author":"Boyer A","year":"2009","unstructured":"Boyer A, Vargas F, Coste F, et al.. Influence of surgical treatment timing on mortality from necrotizing soft tissue infections requiring intensive care management. Intensive Care Med. 2009, 35:847-53. 10.1007\/s00134-008-1373-4","journal-title":"Intensive Care Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1186\/s13017-019-0286-6","article-title":"Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis","volume":"15","author":"Nawijn F","year":"2020","unstructured":"Nawijn F, Smeeing DP, Houwert RM, Leenen LP, Hietbrink F. Time is of the essence when treating necrotizing soft tissue infections: a systematic review and meta-analysis. World J Emerg Surg. 2020, 15:4. 10.1186\/s13017-019-0286-6","journal-title":"World J Emerg Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2015.05.013","article-title":"Necrotizing soft tissue infections after injection therapy: higher mortality and worse outcome compared to other entry mechanisms","volume":"71","author":"Friederichs J","year":"2015","unstructured":"Friederichs J, Torka S, Militz M, B\u00fchren V, Hungerer S. Necrotizing soft tissue infections after injection therapy: higher mortality and worse outcome compared to other entry mechanisms. J Infect. 2015, 71:312-6. 10.1016\/j.jinf.2015.05.013","journal-title":"J Infect"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-008-0695-4","article-title":"Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis","volume":"29","author":"Choi KH","year":"2009","unstructured":"Choi KH, Yoo WH. Necrotizing fasciitis in a patient treated with etanercept for dermatomyositis. Rheumatol Int. 2009, 29:463-6. 10.1007\/s00296-008-0695-4","journal-title":"Rheumatol Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-011-2319-7","article-title":"Necrotizing fasciitis in a pediatric patient treated with etanercept and cyclosporine for macrophage activation syndrome","volume":"33","author":"Buonuomo PS","year":"2013","unstructured":"Buonuomo PS, Campana A, Insalaco A, Bracaglia C, Pardeo M, Cortis E. Necrotizing fasciitis in a pediatric patient treated with etanercept and cyclosporine for macrophage activation syndrome. Rheumatol Int. 2013, 33:1097-8. 10.1007\/s00296-011-2319-7","journal-title":"Rheumatol Int"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-4-367","article-title":"Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report","volume":"4","author":"Smyth A","year":"2010","unstructured":"Smyth A, Houlihan DD, Tuite H, Fleming C, O'Gorman TA. Necrotising fasciitis of the shoulder in association with rheumatoid arthritis treated with etanercept: a case report. J Med Case Rep. 2010, 4:367. 10.1186\/1752-1947-4-367","journal-title":"J Med Case Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.295.19.2275","article-title":"Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials","volume":"295","author":"Bongartz T","year":"2006","unstructured":"Bongartz T, Sutton AJ, Sweeting MJ, Buchan I, Matteson EL, Montori V. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials. JAMA. 2006, 295:2275-85. 10.1001\/jama.295.19.2275","journal-title":"JAMA"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq242","article-title":"Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly","volume":"50","author":"Galloway JB","year":"2011","unstructured":"Galloway JB, Hyrich KL, Mercer LK, et al.. Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderly. Rheumatology (Oxford). 2011, 50:124-31. 10.1093\/rheumatology\/keq242","journal-title":"Rheumatology (Oxford)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.101009","article-title":"Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety","volume":"38","author":"Komano Y","year":"2011","unstructured":"Komano Y, Tanaka M, Nanki T, et al.. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety. J Rheumatol. 2011, 38:1258-64. 10.3899\/jrheum.101009","journal-title":"J Rheumatol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.12659","article-title":"Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: a literature review","volume":"19","author":"Downey C","year":"2016","unstructured":"Downey C. Serious infection during etanercept, infliximab and adalimumab therapy for rheumatoid arthritis: a literature review. Int J Rheum Dis. 2016, 19:536-50. 10.1111\/1756-185X.12659","journal-title":"Int J Rheum Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa027","article-title":"Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study","volume":"72","author":"Bruun T","year":"2021","unstructured":"Bruun T, Rath E, Madsen MB, et al.. Risk factors and predictors of mortality in streptococcal necrotizing soft-tissue infections: a multicenter prospective study. Clin Infect Dis. 2021, 72:293-300. 10.1093\/cid\/ciaa027","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199601253340407","article-title":"Streptococcal infections of skin and soft tissues","volume":"334","author":"Bisno AL","year":"1996","unstructured":"Bisno AL, Stevens DL. Streptococcal infections of skin and soft tissues. N Engl J Med. 1996, 334:240-5. 10.1056\/NEJM199601253340407","journal-title":"N Engl J Med"},{"key":"ref19","article-title":"","year":"2022","unstructured":"Embrel 25mg Subcutaneous Injection ClickWise 1.0mL (Document in Japanese). Pfizer Inc., Tokyo, Japan; 2022. https.\/\/www.pmda.go.jp\/PmdaSearch\/iyakuDetail\/ResultDataSetPDF\/672212_3999424G5020_1_02."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg J","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sj\u00f6lin J, et al.. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003, 37:333-40. 10.1086\/376630","journal-title":"Clin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-017-4786-0","article-title":"Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial","volume":"43","author":"Madsen MB","year":"2017","unstructured":"Madsen MB, Hjortrup PB, Hansen MB, Lange T, Norrby-Teglund A, Hyldegaard O, Perner A. Immunoglobulin G for patients with necrotising soft tissue infection (INSTINCT): a randomised, blinded, placebo-controlled trial. Intensive Care Med. 2017, 43:1585-93. 10.1007\/s00134-017-4786-0","journal-title":"Intensive Care Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/453508-necrotizing-soft-tissue-infection-at-a-self-administered-subcutaneous-etanercept-injection-site-in-an-immunosuppressed-patient-with-rheumatoid-arthritis-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T23:34:57Z","timestamp":1767569697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/453508-necrotizing-soft-tissue-infection-at-a-self-administered-subcutaneous-etanercept-injection-site-in-an-immunosuppressed-patient-with-rheumatoid-arthritis-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,4]]},"references-count":21,"URL":"https:\/\/doi.org\/10.7759\/cureus.100765","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1,4]]}}}